Failed Resolution: An Evidence-Graded Case for Pausing the mRNA Platform
Manufacturing switch, DNA contamination, spike persistence, IgG4 immune tolerance, amyloid microclots, and regulatory failure converge on one …
Read More →
Vaccine Safety
Vaccine Safety
Intranasal Vaccine Brain Risk: The 2026 BPL-1357 Policy Playing Out
The scientific case for pausing NIAID's intranasal whole-virus platforms: direct olfactory-nerve access to the brain, full structural proteins …
Pinsolle's Framework: Spike, mRNA, and the Lab-Origin Question
A write-up of Dr. Typhaine Pinsolle's integrated framework on the SARS-CoV-2 spike, the COVID mRNA injections, and the lab-origin question, with the …
Beyond Blood Clots: PAD4, mRNA Technology, and the Calamari Thrombosis Hypothesis
Molecular analysis of unusual 'calamari clots' reveals connections between lipid nanoparticles, PAD4 citrullination, and treatment-resistant …
Critical Research Gaps: What We Still Don't Know About DNA Contamination
The fundamental questions that remain unanswered about DNA contamination, SV40 promoters, and long-term safety; questions that should have been …
Amyloid Fibrin Microclots in Long COVID: Evidence Review and Treatment Landscape
Peer-reviewed evidence for spike-induced amyloid fibrin microclots in Long COVID, the diagnostic gap created by standard coagulation panels, and the …
mRNA Vaccine DNA Contamination: SV40 Promoter & Integration Risks
Pfizer Process 1 vs Process 2: Manufacturing Changes and Risks
When Pfizer switched from clinical trial production to mass manufacturing, they changed everything from DNA templates to purification methods. …
SV40 DNA Contamination in COVID-19 mRNA Vaccines: The Definitive Investigation
Comprehensive investigation of SV40 DNA contamination in mRNA vaccines, featuring internal regulatory emails, the somatic hypermutation mechanism, …